Jones S M, Thurman R G
Department of Pharmacology, University of North Carolina at Chapel Hill, NC., USA.
Hepatology. 1996 Jul;24(1):163-8. doi: 10.1002/hep.510240127.
A low-flow, reflow model of liver perfusion was used in the rat to investigate the effects of L-arginine on reperfusion injury in the absence of blood elements. In contrast to in vivo studies, L-arginine cannot minimize hypoxia by improving the microcirculation under these special conditions, but rather can only increase oxygen delivery upon reflow. During reflow, lactate dehydrogenase (LDH) release reached a new steady-state value of 35 +/- 3 U/g/h in livers perfused in the absence of L-arginine. L-Arginine (0.1 mmol/L) significantly reduced LDH release during reflow to 14 +/- 1 U/g/h; higher concentrations (1.0-3.0 mmol/L) were less effective and the arginine analogue Nomega-nitro L-arginine methyl ester (L-NAME, 0.3 mmol/L) reversed the protective effect completely. Infusion of the biologically inactive isomer D-arginine (0.1 mmol/L had no effect on the observed reperfusion injury. Malondialdehyde (MDA) release during reflow averaged 92 +/- 10 nmol/g/h and was decreased significantly to 47 +/- 13 nmol/g/h with L-arginine (0.1 mmol/L). Oxygen uptake during reflow was not significantly altered by L-arginine, although the time required to reach steady state values upon reflow was reduced significantly (about twofold), indicating improved microcirculation. Trypan blue distribution time, which is used to index the hepatic microcirculation, was decreased significantly from 330 +/- 17 to 227 +/- 31 seconds by L-arginine, an effect also blocked by L-NAME. Additionally, L-arginine, significantly increased both the rate of entry and exit of fluorescein-dextran, a dye confined to the vascular space, by approximately 50%, also reflecting improved microcirculation. Collectively , these findings indicate that L-arginine protects against hypoxia/reoxygenation injury in a blood-free perfusion model specifically during the reoxygenation period. It is likely that L-arginine rapidly removes substrates for free radical generation by improving the microcirculation.
在大鼠中采用低流量再灌注肝脏模型,研究在无血液成分情况下L-精氨酸对再灌注损伤的影响。与体内研究不同,在这些特殊条件下,L-精氨酸不能通过改善微循环来减轻缺氧,而仅能在再灌注时增加氧输送。再灌注期间,在无L-精氨酸灌注的肝脏中,乳酸脱氢酶(LDH)释放达到新的稳态值35±3 U/g/h。L-精氨酸(0.1 mmol/L)可使再灌注期间LDH释放显著降低至14±1 U/g/h;更高浓度(1.0 - 3.0 mmol/L)效果较差,精氨酸类似物Nω-硝基-L-精氨酸甲酯(L-NAME,0.3 mmol/L)可完全逆转这种保护作用。输注无生物活性的异构体D-精氨酸(0.1 mmol/L)对观察到的再灌注损伤无影响。再灌注期间丙二醛(MDA)释放平均为92±10 nmol/g/h,L-精氨酸(0.1 mmol/L)可使其显著降至47±13 nmol/g/h。L-精氨酸对再灌注期间的氧摄取无显著改变,尽管再灌注时达到稳态值所需时间显著缩短(约两倍),表明微循环得到改善。用于指示肝微循环的台盼蓝分布时间,被L-精氨酸从330±17秒显著缩短至227±31秒,L-NAME也可阻断此效应。此外,L-精氨酸使局限于血管空间的染料荧光素-葡聚糖的进出速率显著增加约50%,也反映了微循环的改善。总体而言,这些发现表明L-精氨酸在无血灌注模型中,特别是在再氧合期,可保护免受缺氧/再氧合损伤。L-精氨酸可能通过改善微循环迅速清除自由基生成的底物。